UK markets open in 16 minutes

NIKKEI 225
38,236.07
-37.98(-0.10%)
HANG SENG
18,183.84
+420.81(+2.37%)
CRUDE OIL
79.56
+0.56(+0.71%)
GOLD FUTURES
2,327.70
+16.70(+0.72%)
DOW
37,903.29
+87.37(+0.23%)
Bitcoin GBP
45,942.88
-1,759.05(-3.69%)

Family finances

Who is the breadwinner in your family and does it matter?

Syros Pharmaceuticals, Inc. (0LC7.L)

LSE - LSE Delayed price. Currency in USD

Add to watchlist

5.48

+0.13

(+2.43%)

At close: 02:59PM BST

Loading interactive chart…

Zacks
Analysts Estimate Syros Pharmaceuticals, Inc. (SYRS) to Report a Decline in Earnings: What to Look Out for
Syros Pharmaceuticals (SYRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
The Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals
Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals are part of the Zacks top Analyst Blog.
Zacks
Syros (SYRS) Up on FDA Fast Track Tag for Tamibarotene in AML
The FDA bestows a Fast Track Designation to Syros' (SYRS) pipeline candidate, tamibarotene, in combination with venetoclax and azacitidine to treat newly diagnosed acute myeloid leukemia. Stock rises.